Genomic analysis of human brain metastases treated with stereotactic radiosurgery reveals unique signature based on treatment failure

Jack M. Shireman, Quinn White, Zijian Ni, Chitrasen Mohanty, Yujia Cai, Lei Zhao, Namita Agrawal, Nikita Gonugunta, Xiaohu Wang, Liam Mccarthy, Varshitha Kasulabada, Akshita Pattnaik, Atique U. Ahmed, James Miller, Charles Kulwin, Aaron Cohen-Gadol, Troy Payner, Chih Ta Lin, Jesse J. Savage, Brandon LaneKevin Shiue, Aaron Kamer, Mitesh Shah, Gopal Iyer, Gordon Watson, Christina Kendziorski, Mahua Dey*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Stereotactic radiosurgery (SRS) has been shown to be efficacious for the treatment of limited brain metastasis (BM); however, the effects of SRS on human brain metastases have yet to be studied. We performed genomic analysis on resected brain metastases from patients whose resected lesion was previously treated with SRS. Our analyses demonstrated for the first time that patients possess a distinct genomic signature based on type of treatment failure including local failure, leptomeningeal spread, and radio-necrosis. Examination of the center and peripheral edge of the tumors treated with SRS indicated differential DNA damage distribution and an enrichment for tumor suppressor mutations and DNA damage repair pathways along the peripheral edge. Furthermore, the two clinical modalities used to deliver SRS, LINAC and GK, demonstrated differential effects on the tumor landscape even between controlled primary sites. Our study provides, in human, biological evidence of differential effects of SRS across BM's.

Original languageEnglish (US)
Article number109601
JournaliScience
Volume27
Issue number4
DOIs
StatePublished - Apr 19 2024

Funding

Funding: This work was supported by the NIH K08NS092895 grant (MD), IU Value Research grant (MD) . JMS is partly supported by NIH/ NINDS T32 NS105602 . The authors thank the patients who participated in the trial and contributed invaluable samples for this research and whom all this work is dedicated. Funding: This work was supported by the NIH K08NS092895 grant (MD), IU Value Research grant (MD). JMS is partly supported by NIH/NINDS T32 NS105602. JMS/QW/ZN/GC/CM conducted bioinformatic analysis, LB/YZ conducted the clinical trial statistical analysis, JMS/LZ/XW/AP/LM/VK/NG conducted in vitro experiments and isolated/prepared samples for sequencing, AA/GP contributed to the article formulation and provided sequencing samples and cell lines, NA/JM/CK/ACG/TP/CL/JS/BL/KS/AK/MS/GW/MD provided clinical consultation and/or operated on patients on trial, JMS/MD/CK wrote the article, MD supervised the project and the clinical trial. The authors declare no competing interests.

Keywords

  • Cancer
  • Cancer systems biology
  • Genomic analysis
  • Genomics

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Genomic analysis of human brain metastases treated with stereotactic radiosurgery reveals unique signature based on treatment failure'. Together they form a unique fingerprint.

Cite this